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Summary 
Aromatherapy is the most widely used complementary therapy in nursing 
practice, and uses essential oils from fragrant plants to relieve health prob-
lems and improve quality of life in general. The healing properties of aro-
matherapy are claimed to include relaxation and sleep, pain relief and the 
reduction of depressive symptoms.  
This systematic review evaluates the evidence about aromatherapy 
in order to determine whether or not aromatherapy is effective for pain relief 
and psychological problems, and how safe it is.  
Ten randomised controlled trials (RCTs) of fair to good quality are 
identified and included in the review. The indications covered by these stud-
ies are procedural anxiety, anxiety in cancer patients, agitation in dementia 
and pain. According to the evidence, aromatherapy is useful for some condi-
tions, such as agitation in dementia, but not for others, including procedural 
anxiety. The evidence as to the safety of aromatherapy is inadequate. Exten-
sive and good quality RCTs are required to obtain a clear picture as to 
whether aromatherapy is effective for psychological problems or pain, and 
whether it is a safe treatment. 
 
aromatherapy claimed 
to have healing 
properties 
 
this review evaluates 
the evidence about 
aromatherapy 
heterogeneous results 
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1 Aromatherapy for pain relief and 
psychological problems 
1.1 Background 
Aromatherapy is the most widely used complementary therapy in nursing 
practice [1], and is part of the discipline of phytotherapy (the use of whole 
plants or parts of plants for medicinal purposes). It uses essential oils from 
fragrant plants (such as Peppermint, Sweet Marjoram and Rose) to help re-
lieve health problems and improve quality of life in general. The healing 
properties of aromatherapy are claimed to include relaxation and sleep, pain 
relief and reduction of depressive symptoms [2]. 
It is often hailed as a relatively inexpensive and safe treatment compared 
with conventional methods, and thus, if a clinically relevant benefit could be 
demonstrated, it might become more widely used. However, aromatherapy is 
regarded by many as a quack treatment, no more effective than a placebo. As 
healthcare becomes increasingly driven by evidence-based practice, there is 
a need to objectively evaluate the efficacy of aromatherapy [1]. This system-
atic review summarises and analyses the evidence available as to the effect of 
aromatherapy on psychological problems and pain compared with conven-
tional treatment and placebo. Its conclusion is based on the GRADE system 
for evaluating evidence (see [3]). 
1.2 Description of treatment 
The essential oils can be used in oil burners, in bath water, be massaged into 
the skin, inhaled through an oxygen facemask, or simply inhaled. Thus the 
aroma stimulates the olfactory senses, or the oils are absorbed into the skin 
[4]. Aromatherapy is thought to affect mood by promoting the release of 
neurotransmitters, which reduce pain and create a feeling of well-being [1]. 
Due to the pleasant fragrances and methods of application, aromatherapy is 
often said to be a very pleasant treatment. 
1.3 Indication and therapeutic aim 
The indications covered in this review are pain, in any patient, and psycho-
logical problems related to anxiety and depression. The therapeutic aim is 
the reduction of any of these symptoms. 
1.4 Treatment costs 
While the costs of aromatherapy treatment will vary according to the type 
and duration of the treatment, it is assumed that they are low compared with 
aromatherapy claimed 
to have healing 
properties 
there is a need to 
establish whether 
aromatherapy is more 
effective than placebo 
 
this review evaluates 
the evidence 
aromatherapy is said to 
affect mood by 
promoting the release of 
neurotransmitters 
indications: pain and 
pschological problems 
therapeutic aim: 
improvement of 
symptoms 
the treatment costs are 
assumed to be low 
Aromatherapy 
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conventional treatments, or will not add a significant cost if used in addition 
to other treatments. Wiebe [5] reflects that aromatherapy is ‘relatively inex-
pensive’, and as such this appears to be an argument used to encourage peo-
ple to try aromatherapy, though its precise effects are unknown. At the same 
time, one ought to consider that if aromatherapy is used in conjunction with, 
for example, massage, the overall costs may increase. 
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2 Literature search and selection 
2.1 PICO questions 
1. Is aromatherapy effective in the treatment of stress, anxiety, and depres-
sion, both in general and in comparison to conventional treatments or pla-
cebo? 
2. Is aromatherapy effective for pain relief compared with conventional 
treatment or placebo? 
3. Is aromatherapy in the treatment of the above conditions safe, in compari-
son to conventional treatments or placebo? 
2.2 Inclusion criteria 
Table 2.2-1 Inclusion criteria 
Population Patients with pain. Patients with psy-
chological problems. 
 
Intervention Any aromatherapy treatment. 
 
Comparison Conventional treatment. Placebo. 
 
Outcomes Pain reduction. Improvement of psy-
chological problems. 
 
Study design Prospective studies with control group 
of good or fair quality. N ≥ 20.  
 
2.3 Literature search 
The systematic literature search was carried out on 14.11.07 in the following 
databases. 
b Medline via Ovid  b Embase via Ovid  b CCRCT (Cochrane Library) via Ovid  b CDSR (Cochrane Library) via Ovid  b NHS EED-Datenbank des CRD York  b HTA - Datenbank des CRD York  b DARE - Datenbank des CRD York 
PICO questions 
inclusion criteria 
literature search 
Aromatherapy 
for pain relief and 
psychological problems 
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The search was limited to English and German language literature and cov-
ered the entire time span of the databases. 
After the removal of duplicates, 351 bibliographical references were avail-
able. The exact search strategy can be requested at the LBI for HTA. 
By means of a hand search, 244 additional references were identified, which 
raised the overall number of hits to 595. 
2.4 Literature selection 
Overall, 595 Articles were available for the literature selection. The selection 
process is depicted in Figure 2.4-1 below.  
 
Figure 2.4-1: Depiction of the selection process (QUORUM tree) 
 
literature selection 
Full texts: 
n = 40 
Excluded references: 
n = 543 
Full texts included: 
n = 10 
• 5 RCTs 
• 3 open-label RCTs 
• 1 cross-over RCT 
• 1 single-blinded RCT 
Full texts excluded: 
 
n = 27 
• 9 poor quality RCTs 
• 1 case study 
• 2 systematic reviews 
• 3 Korean 
• 2 n < 20 
• 1 wrong outcome 
• 1 wrong population 
• 2 wrong indication and 
intervention 
• 1 wrong indication 
• 1  project record 
• 1 interview 
• 3 not studies 
Full text not available: 
n = 12 
Only published 
as abstract: 
n = 0 
Background  
literature 
n = 3 
References identified in  
literature search: 
n  = 595 
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3 Assessment of the quality of the studies 
The evaluation of the quality of the studies was carried out by two reviewers, 
independently of each other. Conflicting views were settled by means of dis-
cussion and consensus, or through the involvement of a third person. An ex-
act list of the criteria that were used for the evaluation of the internal valid-
ity of the studies can be found in the internal manual of the LBI-HTA [6]. 
4 Data extraction 
The extraction of data was carried out by one person. A second person 
checked the completeness and accuracy of the data. 
4.1 Presentation of the study results 
Ten randomised controlled trials (RCTs) [5, 7-15] were included to answer 
the PICO questions (see Chapter 2.1). 
 
quality assessment of 
studies carried out by 
two reviewers 
data extraction carried 
out by one person 
10 RCTs included 
Aromatherapy 
for pain relief and 
psychological problems 
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Table 4.1-1: Study results 
Author, 
Year, Refer-
ence num-
ber 
Ballard et al. 
2002 [7] 
 
Graham et al. 
2003 [8]  
Han et al. 
2006 [9] 
Lin et al. 
2007 [10] 
Muzzarelli et 
al. 2006 [11] 
 
Shin et al. 
2007 [12] 
Soden et al. 
2004 [13] 
Wiebe et al., 
2000 [5]  
Wilkinson et 
al. 1999 [14] 
Wilkinson et 
al. 2007 [15] 
Country UK Australia Korea China USA Korea United King-
dom 
Canada United King-
dom 
United King-
dom 
Sponsor Mental 
Health 
Foundation 
NR NR NR NR NR Foundation 
for Inte-
grated Medi-
cine 
NR NR Cancer Re-
search UK, 
Marie Curie 
Cancer Care, 
Macmillan 
Cancer Sup-
port, Dimbleby 
Cancer Care 
Study de-
sign 
RCT RCT RCT Cross-over 
RCT 
open-label 
RCT 
open-label 
RCT 
open-label 
RCT 
RCT RCT single-
blinded RCT 
Quality Fair Good Fair Fair Fair Fair Fair Good Fair Fair 
Number of 
patients 
72 313 67 70 118 30 42 66 103 288 
Lost to fol-
low up 
1.4% 6-9% 0% 0% Not reported 0% 14% 0% 15.5% 23% 
Study Popu-
lation 
Nursing 
home pa-
tients with  
dementia 
and clini-
cally signifi-
cant agita-
tion 
Patients un-
dergoing ra-
diotherapy 
College stu-
dents experi-
encing dys-
menorrhea 
Nursing 
home pa-
tients with 
dementia 
and agita-
tion 
Patients 
scheduled for 
elective gas-
trointestinal 
endoscopic 
procedure 
Stroke pa-
tients with 
hemiplegic 
shoulder pain 
Patients with 
advanced 
cancer 
Women wait-
ing for surgical 
abortions 
Patients with 
cancer 
Patients with 
advanced 
cancer  
∅ Patient 
age 
 
Interven-
tion:77.2 
Control: 
79.6 
65 Aromather-
apy: 25 
Massage: 20 
No Interven-
tion: 22 
78 52 Intervention: 
60.6 
Control: 63.1 
73 Interven-
tion:26.9 
Control: 26.1 
53.1 52.1 
Indication 
for aro-
matherapy 
Agitation in 
severe de-
mentia 
Anxiety dur-
ing radiother-
apy 
Dysmenor-
rhea  
Agitation in 
dementia 
Preproce-
dural anxiety 
Hemiplegic 
shoulder pain 
Physical and 
psychological 
symptoms in 
patients with 
advanced 
cancer 
Preoperative 
anxiety 
Anxiety in 
patients with 
cancer 
Anxiety or 
depression in 
patients with 
cancer 
Data extraction 
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Intervention Twice daily 
active aro-
matherapy 
treatment 
with Melissa 
oil combined 
with base 
lotion ap-
plied to face 
and arms 
Inhalation of: 
 essential oils 
of lavender, 
bergamot, and 
cedarwood  
during radio-
therapy 
Abdominal 
massage us-
ing essential 
oils of  laven-
der, clary 
sage, and 
rose 
Inhalation 
of essential 
lavender oil 
using a 
aroma dif-
fuser 
Inhalation of 
essential 
Lavender oil 
Aromather-
apy with es-
sential oils of 
rosemary, 
lavender, and 
peppermint 
plus acupres-
sure 
Weekly  
massages 
with lavender 
essential oil 
Sniffing mix-
ture of ber-
gamot and ge-
ranium oils 
Massage us-
ing carrier oil 
plus Roman 
chamomile 
essential oil 
Individual-
ized aro-
matherapy 
massage with 
various es-
sential oils  
Control Twice daily 
application 
of sunflower 
oil combined 
with base 
lotion to 
face and 
arms 
Inhalation of: 
1) carrier oil 
(almond cold 
pressed vege-
table oil) as a 
non-fragrant 
placebo 
2) fraction-
ated oils of 
lavender, ber-
gamot, and 
cedarwood 
with carrier oil 
as a fragrant 
placebo 
  during radio-
therapy 
1) abdominal 
massage us-
ing almond 
oil 
2) No treat-
ment 
Inhalation 
of sunflower 
oil using a 
aroma dif-
fuser 
Inhalation of 
grapeseed oil 
Acupressure 1) Weekly 
massages 
with inert 
carrier oil 
2) No inter-
vention 
Sniffing hair 
conditioner 
containing 
Brazil nut oil 
Massage us-
ing carrier oil 
 Usual sup-
portive care  
Duration of 
treatment 
4 weeks 15-20 minutes 15 minutes  Nightly 
treatments 
over 3 
weeks,  
5 minutes  20 minutes 
twice daily 
over 2 weeks 
30 mins per 
week, 4 
weeks 
10 minutes 3 massages 
over 3 weeks 
1 hour mas-
sage weekly 
across 4 
weeks 
Main out-
come meas-
ures  
Change in 
total CMAI  
scores 
HADSA for 
anxiety  
VAS for men-
strual 
cramps. Ver-
bal multidi-
mensional 
scoring sys-
tem for dys-
menorrhea 
symptoms. 
Chinese 
CMAI 
State compo-
nent of STAI 
Korean ver-
bal pain rat-
ing system, 
0-8 (0 = not 
at all) 
VAS of pain 
intensity. 
Hospital 
Anxiety and 
Depression 
Scale (HAD). 
10-point scale 
rating subjec-
tive anxiety (0 
= no anxiety) 
STAI Change in 
clinical and 
self-reported 
anxiety 
and/or de-
pression 
based on a 
shortened 
version of 
the Struc-
tured Clinical 
Interview  
Aromatherapy 
for pain relief and 
psychological problems 
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Results 
 
 
Higher re-
duction in 
CMAI scores 
with aro-
matherapy 
than with 
placebo: 
(-35% vs.  
-11%;  
P<0.001) 
 
Fewer pa-
tients on 
non-
fragrant pla-
cebo had  
HADSA 
scores ≥7 
than those 
on essential 
oils or fra-
grant pla-
cebo (13% 
vs. 26% (P = 
0.04) vs. 
23% (P = 
0.04 )  
Women on 
aromather-
apy reported 
greater re-
ductions of 
cramps on 
the second 
day of men-
struation 
than those 
with massage 
or no inter-
vention (-4.5, 
vs. -0.5 vs. 
0.0; P= NR) 
 
Patients on 
aromatherapy 
had a greater 
change of 
CCMAI scores 
than those on 
placebo (-4.4 
vs. -0.04; P = 
NR)  
 
No signifi-
cant differ-
ence in SA 
between pre- 
and post-
treatment in 
control or 
experimental 
groups (Data 
NR).  
Significantly 
greater 
changes in 
pain scores  
with aro-
matherapy (-
4.0 vs. -2.0; P 
=0.001) 
No signifi-
cant differ-
ences of 
changes in 
VAS ( 0.19 vs. 
0.32 vs. 0.78; 
P = NR) or 
HAD (Anxi-
ety: -0.5 vs. 
0.0 vs. 0.0; P 
= NR) from 
baseline to 
endpoint 
among  aro-
matherapy,  
massage, and 
no interven-
tion groups 
 Similar re-
duction in 
anxiety 
scores be-
tween inter-
vention and 
control 
groups (-1.1 
vs. -1.0 
points; 
P=0.71) 
Statistically 
significant 
reduction in 
SA between 
pre- and 
post-
treatment af-
ter each mas-
sages in ex-
perimental 
and control 
and groups 
(1st massage: 
-14.49 vs. -
14.46; P= NR. 
2nd massage: 
-11.65 vs. -
14.73; P= NR. 
3rd massage: -
13.79 vs. -
12.23; P= NR) 
 
Patients who 
received aro-
matherapy 
massage had a 
significantly 
greater im-
provement of 
clinical anxi-
ety and/or de-
pression after 
6 weeks post-
randomisation 
(OR 1.4 95% 
CI 1.1 to 1.9; 
P=0.01) 
 
The difference 
was not statis-
tically signifi-
cant after 
10 weeks post-
randomisation 
(OR 1.3, 95% 
CI 0.9 to 1.7; P 
= 0.1) 
Adverse 
events 
NR NR None. None. NR NR NR NR NR NR 
Abbreviations: 
 NR: Not reported 
OR: Odds ratio 
CI: Confidence interval 
CMAI: Cohen-Mansfield Agitation inventory 
HADS: Hospital Anxiety and Depression Scale 
HADSA: Hospital Anxiety and Depression Scale – Anxiety score 
VAS: Visual analogue scale 
CCMAI: Chinese Cohen-Mansfield Agitation inventory 
STAI: State-Trait Anxiety Inventory 
SA: State Anxiety 
Data extraction 
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4.2 Efficacy 
The populations included in the trials varied, and included patients with 
preprocedural anxiety, agitation in dementia, anxiety in cancer patients and 
various types of pain. The efficacy of aromatherapy is evaluated for each in-
dication. 
4.2.1 Efficacy of aromatherapy for procedural 
anxiety 
Two good quality RCTs [5, 8] and a fair quality open label RCT [11] re-
ported on the efficacy of aromatherapy in reducing procedural anxiety for a 
variety of procedures compared with placebo. Details of these are summa-
rised in table 4.1-1.  No studies compared aromatherapy for procedural 
anxiety with conventional treatment. 
Wiebe [5] reported an insignificant difference between the intervention 
group and the control group: A 1.1 point reduction in subjective anxiety 
score (10 point rating) in the intervention group compared with a 1.0 point 
reduction in the control group, with a p-value of 0.71. Muzzarelli et al. [11] 
reported that there was no significant difference in SA between pre- and 
post-treatment in control or experimental groups, but the data was not re-
ported. In the largest of the RCTs (n=313) Graham et al. [8] found that 
post-treatment HASDA scores were significantly lower in the non-fragrant 
placebo group than in the essential oils or fragrant placebo group (13% vs. 
26% vs. 23%; P=0.04).  
Thus there is consistency across studies: Aromatherapy is not more effective 
than placebo in reducing procedural anxiety.  The duration of inhalation 
appears to make no difference, as the result was the same with a 5 minute 
inhalation [11] as for a 15-20 minute inhalation [8]. The strength of the evi-
dence is moderate. 
4.2.2 Efficacy of aromatherapy for agitation in 
dementia 
One RCT [7] and one cross-over RCT [10] , both of fair quality, and similar 
in sample size and duration, reported on the efficacy of aromatherapy in re-
ducing agitation in dementia patients compared with placebo. Details of 
these are summarised in table 4.1-1.  No studies compared aromatherapy 
with conventional treatment in the treatment of agitation in dementia pa-
tients.  
Ballard [7] reported that the aromatherapy group had a 35% reduction in 
Cohen-Mansfield agitation inventory (CMAI) scores than the placebo group, 
where the reduction was 11%. The difference was statistically significant (P 
< 0.001). This particularly large effect may have been influenced by poor 
cluster randomisation was used. However, the result corresponds to that 
found by Lin et al. [10], where patients on aromatherapy experienced a 
effiacy of aromatherapy 
evaluated for 4 
indcations 
 
 
3 RCTs on aromatherapy 
for procedural anxiety 
aromatherapy is not 
more effective than 
placebo 
strength of evidence is 
moderate 
 
2 RCTs on aromatherapy 
for agitation in 
dementia 
Aromatherapy 
for pain relief and 
psychological problems 
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greater change in Chinese CMAI than those on placebo (4.4 vs. 0.04). How-
ever, as the p-value was not reported, it is not certain whether this difference 
is statistically significant. 
The treatment effect is consistent across studies, with aromatherapy reduc-
ing agitation to a greater extent than placebo, but methodological flaws may 
have biased results. The strength of the evidence is moderate. 
4.2.3 Efficacy of aromatherapy for anxiety in 
cancer patients 
One RCT [14], one open label RCT [13] and one single-blind RCT [15], all 
of fair quality, reported on the effects of aromatherapy on anxiety in cancer 
patients. Details of these are summarised in table 4.1-1. 
Wilkinson et al. 1999 [14] reported a statistically significant reduction in SA 
between pre- and post-treatment in aromatherapy and placebo groups, but 
no p-value as to the statistical difference between the two groups. Soden et 
al. [13] reported that there was no significant difference in the change in the 
anxiety score of the Hospital Anxiety and Depression Scale (HADSA) be-
tween aromatherapy, massage (placebo) and no intervention, but also gave 
no p-value. Small sample sizes (103 in Wilkinson et al. 1999 and 42 in Soden 
et al.) may have led to inaccurate results. 
In the largest of the three trials (n=288), Wilkinson et al. 2007 [15] com-
pared aromatherapy with usual supportive care and found that patients re-
ceiving aromatherapy had a significantly greater improvement in clinical 
anxiety and/or depression 6 weeks post-randomisation (OR 1.4 95% CI 1.1 
to 1.9; P = 0.01) but not 10 weeks post-randomisation (OR 1.3, 95% CI 0.9 to 
1.7;  P = 0.1. 
All three studies are of fair quality, but unfortunately the results for com-
parisons between aromatherapy and placebo are inconsistent. Also, one fair 
quality study comparing aromatherapy with conventional supportive care 
for cancer patients is not sufficient to determine the comparative effects of 
aromatherapy on cancer patients. More RCTs are required to establish the 
effect of aromatherapy on anxiety in cancer patients. The strength of the e-
vidence is very low. 
4.2.4 Efficacy of aromatherapy for pain 
Two open label RCTs [12, 13] and one RCT [9], all of fair quality, report on 
the effectiveness of aromatherapy for pain compared with placebo. Details of 
these are summarised in table 4.1-1. 
Soden et al. [13] looked at aromatherapy for pain in cancer patients and 
found no significant differences in changes in VAS between the aromather-
apy group (0.19 point reduction) and the placebo group (0.32). The p-value 
was not reported. Han et al. [9] reported that women on aromatherapy re-
ported a greater reduction in cramps on the second day of menstruation than 
those with massage or no intervention (-4.5 vs. -0.5 vs. 0.0). However, the sta-
tistical significance of this difference was not reported. For hemiplegic 
shoulder pain, Shin et al. [12] found significantly greater changes in aro-
matherapy recipients than the placebo group (4.0 vs. 2.0; P=0.001). 
aromatherapy more 
effective than placebo. 
strength of evidence is 
moderate 
3 RCTs  on 
aromatherapy for 
anxiety in cancer 
patients 
inconsistent results 
 
strength of evidence 
very low 
 
3 RCTs on aromatherapy 
for pain 
Data extraction 
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The results of these studies are inconsistent, but one ought to take into the 
consideration the fact that they all report on different types of pain. Also, 
the sample sizes in all three RCTs were small, between 30 and 70. Further 
RCTs are required to establish the pain reducing effect of aromatherapy. 
The strength of the evidence is low. 
4.3 Safety of aromatherapy 
Few of the studies make references to side-effects or the general safety of a-
romatherapy. However, this seems to reflect the fact that aromatherapy is 
regarded as relatively safe. Wiebe [5] mentions the safety of aromatherapy in 
passing (‘relatively safe’). Two report no side effects [9, 10], and one [7] re-
ports that there were no significant side effects but does not describe the side 
effects that were experienced. The strength of the evidence is low. 
 
inconsistent results, 
but for different 
types of pain 
strength of evidence 
low 
adverse events under-
reported. 
aromatherapy likely to 
be safe 
strength of evidence is 
low 
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5 Strength of the Evidence 
The GRADE system is used to evaluate the strength of the (see [3]).  
GRADE uses the following classifications and definitions to evaluate the 
strength of the evidence. 
b high: further research is very unlikely to change our confidence in 
the estimate of effect 
b Moderate: Further research is likely to have an important impact 
on our confidence in the estimate of effect and may change the es-
timate 
b Low: Further research is very likely to have an important impact on 
our confidence in the estimate of effect and is likely to change the 
estimate  
b Very low: any estimate of effect is very uncertain 
The evidence profile of aromatherapy including GRADE ratings is shown in 
table 5-1 below. 
 
GRADE system 
Aromatherapy 
for pain relief and 
psychological problems 
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Table 5-1: Evidence profile of aromatherapy  
1. Muzzarelli: No Table 1; flawed randomisation  
2. Ballard: Flawed cluster randomisation 
Lin: No p-value 
3. Wilkinson 1999: No description of blinding 
Wilkinson 2007: High drop-out rate 
Soden et al.: Low power 
4. 4 Soden et al.: Low power 
Han: Inadequate blinding and randomisation; no allocation concealment 
5. Lin: No p-value 
Han: Inadequate blinding and randomization; no allocation concealment 
 
 
Number  
of stud-
ies/patients 
Design Methodological 
quality 
Consistency 
of results 
Directness Size of effect Other mo-
dificatory 
factors 
Strength of 
the collective 
evidence  
Outcome: Reduction of procedural anxiety (compared with control) 
3/226 RCT Fair1 Yes Yes No significant differ-
ences between aro-
matherapy and placebo  
None. Moderate 
Outcome: Reduction of agitation in dementia (compared with control) 
2/142 RCT Fair2 Yes Yes Significantly higher re-
duction in agitation 
with aromatherapy 
than with placebo 
None. Moderate  
Outcome: Reduction of anxiety in cancer patients (compared with control) 
3/433 RCT Fair3 No Yes Significant or no sig-
nificant differences be-
tween aromatherapy 
and placebo 
None. Very low 
Outcome: Reduction in pain (compared with control) 
3/139 RCT Fair 4 No Yes Significant or no sig-
nificant differences be-
tween aromatherapy 
and placebo 
None. Low 
Outcome: Safety 
2/137 RCT Fair5 Yes Yes No side-effects None. Moderate 
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6 Conclusion 
Aromatherapy is used for many different conditions and it seems unlikely 
that it works equally well, if at all, for all of them. According to the evidence, 
it is more effective than placebo for agitation in dementia but not for proce-
dural anxiety. This suggests that while it is useful for certain conditions, in 
others it has no effect, or at least no effect beyond that of placebo.  
Thus aromatherapy needs to be evaluated in good quality RCTs for all indi-
cations for which it is said to have a beneficial effect.  Obtaining comprehen-
sive evidence on aromatherapy will therefore be time-consuming and costly. 
On the other hand, aromatherapy is regularly cited as a low-cost treatment 
and appears to have few side effects (though again, further RCTs are re-
quired to demonstrate this). Therefore, there is little to discourage individu-
als from experimenting with aromatherapy for pain relief and relaxation. 
Overall, the evidence about aromatherapy for pain relief and the reduction 
of psychological problems is limited, and results largely heterogeneous. 
RCTs suggest that aromatherapy may well be effective for certain condi-
tions. However, for the various indications for which RCTs exist, the 
strength of the evidence is never better than moderate. Extensive RCTs are 
required to obtain a clear picture of whether aromatherapy is effective for 
psychological problems or pain, and whether it is a safe treatment. 
 
overall, 
heterogeneous results 
good quality RCTs 
required for all 
indications 
aromatherapy appears 
to be a low-cost 
treatment with few 
side-effects 
there is little evidence 
about aromatherapy for 
pain and psychological 
problems 
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